Komori
Other Disclosures6029Artra Group CorporationInformation and Communications, Services and Others

Notice Regarding Approval for Listing on the Nagoya Stock Exchange Main Market

Atra Group has received approval to list on the Nagoya Stock Exchange Main Market. The shares are scheduled to be dual-listed with the Tokyo Stock Exchange Standard Market from 17 September 2026.

Worth reading
45Recurring
0–100. This measures how worthwhile something is to read, not how good or bad the company is.
Direction
Improvement
Direction inferred from the company’s description.
Scale
—
Displayed only when the document provides numerical figures.
Wording
Definitive
How definitive the wording is.

Announced details

A-COMS management support platform for acupuncture, moxibustion and osteopathic clinics
Applicable field (uses covered by this announcement)

Management support for acupuncture, moxibustion and osteopathic clinics

Launch date17 September 2026 (予定)
Relationship between the counterparty and the company
Artra Group Corporation6029
Relationship with the Company

The listing venue for our shares. The relationship is that of a dual listing in addition to the existing Tokyo Stock Exchange Standard Market listing.

CounterpartyNagoya Stock Exchange

The stock exchange operating the Nagoya Stock Exchange Main Market. Other information, including location, representative, capital and year established, is not disclosed.

In this announcement the company addresses none of Contract Value / Offering price / Impact on Business Performance.

Source (materials cited by the company)

Nagoya Stock Exchange website

Announced details
ItemDetails
Names of Products / Services CoveredA-COMS management support platform for acupuncture, moxibustion and osteopathic clinics
CounterpartyNagoya Stock Exchange
Counterparty overviewThe stock exchange operating the Nagoya Stock Exchange Main Market. Other information, including location, representative, capital and year established, is not disclosed.
Relationship with the CompanyThe listing venue for our shares. The relationship is that of a dual listing in addition to the existing Tokyo Stock Exchange Standard Market listing.
Launch date17 September 2026 (予定)
Applicable areaManagement support for acupuncture, moxibustion and osteopathic clinics
SourceNagoya Stock Exchange website
Items this document does not state (11)
Contract ValueOffering priceContract DateAward/certification nameAwarding / certifying bodyRegistration number and expiry dateLocationLocation scaleQuantitative EffectsUsage historyImpact on Business Performance

These are items the company does not state in this document. We do not leave them blank, nor fill them in from other sources or by inference.

The reasons the company gives

The company's own explanation, not something inferred from the numbers.

To broaden access to new individual investor segments and enhance dialogue with existing shareholders and investors. The dual listing is also intended to expand the investor base, improve share liquidity, increase the number of shareholders and stimulate trading.

How to read this page

This is not the documentKomori reads the disclosure the company filed and writes this summary. Figures are as stated by the company and are not audited.
Weight is not a verdictIt measures how much this changes what the company had already told the market. It is not a view on the shares.
Corrections happenIf the company reissues this disclosure, the page is rebuilt from the corrected version and the revision number moves up.
Notice Regarding Approval for Listing on the Nagoya Stock Exchange Main Market | Artra Group Corporation (6029) timely disclosure | Komori